LGC Clinical Diagnostics VALIDATE® Tumor Markers Calibration Verification / Linearity Test Kit - HSA Registration DE0509899
Access comprehensive regulatory information for LGC Clinical Diagnostics VALIDATE® Tumor Markers Calibration Verification / Linearity Test Kit in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0509899 and owned by LGC Clinical Diagnostics, Inc. The device was registered on October 11, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
VALIDATE Tumor Markers Calibration Verification / Linearity Test Kit solutions are intended for in vitro diagnostic use in the determination of linearity, calibration verification and verification of reportable range on automated instrument systems for the following analytes: cancer antigen 15-3 (CA 15-3), cancer antigen 19-9 (CA 19-9), cancer antigen 125 (CA 125) and carcinoembryonic antigen (CEA).